share_log

Senti Biosciences | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Senti Biosciences | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Senti Biosciences | PRE 14A:並購重組委托聲明
美股sec公告 ·  05/18 05:23
牛牛AI助理已提取核心訊息
Senti Biosciences, Inc. (Senti) has announced the upcoming 2024 Annual Meeting of Stockholders, scheduled to be held virtually on July 10, 2024. The meeting will address several key proposals, including the ratification of KPMG LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2024, and amendments to the company's Second Amended and Restated Certificate of Incorporation. These amendments involve the inclusion of an officer exculpation provision and the authorization of a reverse stock split of the company's common stock at a ratio determined by the board of directors. Additionally, the meeting will consider the adjournment of the Annual Meeting to solicit additional proxies if necessary. The board has fixed May 13, 2024, as the record date for stockholder entitlement to notice and voting rights at the meeting. Senti Biosciences is utilizing the SEC's 'Notice and Access' rule to furnish proxy materials online, reducing environmental impact and mailing costs. Stockholders will be able to vote electronically and submit questions during the virtual meeting.
Senti Biosciences, Inc. (Senti) has announced the upcoming 2024 Annual Meeting of Stockholders, scheduled to be held virtually on July 10, 2024. The meeting will address several key proposals, including the ratification of KPMG LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2024, and amendments to the company's Second Amended and Restated Certificate of Incorporation. These amendments involve the inclusion of an officer exculpation provision and the authorization of a reverse stock split of the company's common stock at a ratio determined by the board of directors. Additionally, the meeting will consider the adjournment of the Annual Meeting to solicit additional proxies if necessary. The board has fixed May 13, 2024, as the record date for stockholder entitlement to notice and voting rights at the meeting. Senti Biosciences is utilizing the SEC's 'Notice and Access' rule to furnish proxy materials online, reducing environmental impact and mailing costs. Stockholders will be able to vote electronically and submit questions during the virtual meeting.
森蒂生物科學公司(Senti)宣佈即將舉行的2024年年度股東大會,該會議定於2024年7月10日虛擬舉行。會議將討論幾項關鍵提案,包括批准畢馬威會計師事務所作爲截至2024年12月31日的財政年度的獨立註冊會計師事務所,以及對該公司第二經修訂和重述的公司註冊證書的修訂。這些修正包括納入一項高管免責條款,並授權按董事會確定的比率對公司普通股進行反向分割。此外,如有必要,會議將考慮休會,以徵集更多代理人。董事會已將2024年5月13日定爲股東有權在會議上獲得通知和投票權的記錄日期。Senti Biosciences正在利用美國證券交易委員會的 “通知和訪問” 規則在線提供代理材料,從而減少環境影響和郵寄成本。股東將能夠在虛擬會議期間進行電子投票並提交問題。
森蒂生物科學公司(Senti)宣佈即將舉行的2024年年度股東大會,該會議定於2024年7月10日虛擬舉行。會議將討論幾項關鍵提案,包括批准畢馬威會計師事務所作爲截至2024年12月31日的財政年度的獨立註冊會計師事務所,以及對該公司第二經修訂和重述的公司註冊證書的修訂。這些修正包括納入一項高管免責條款,並授權按董事會確定的比率對公司普通股進行反向分割。此外,如有必要,會議將考慮休會,以徵集更多代理人。董事會已將2024年5月13日定爲股東有權在會議上獲得通知和投票權的記錄日期。Senti Biosciences正在利用美國證券交易委員會的 “通知和訪問” 規則在線提供代理材料,從而減少環境影響和郵寄成本。股東將能夠在虛擬會議期間進行電子投票並提交問題。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。